National Institute for Health Research (NIHR) Principal Investigator (PI) Oversight Masterclass, Institute of Translational Medicine (ITM), Birmingham (16/01/17)
National Institute for Health Research Good Clinical Practice (NIHR GCP) training on 09/03/12, 17/02/15 and 06/02/17
2015–2016: Co-investigator for the DAPSA [Dapagliflozin in South Asians] Study (A randomised double-blind placebo controlled trial) [Protocol designed, funding acquired, however, trial ended due to low feasibility]
2014–2016: Co-supervisor for an MD project. What is the relationship of revascularisation and improvement in microcirculation to wound healing and peripheral neuropathy in diabetic foot disease? An observational cohort study
2014–2015: Co-investigator for a Randomised Controlled Study to Evaluate the Impact of Novel Glucose Sensing Technology on HbA1c in Type 2 Diabetes [The REPLACE Study] [FreeStyle Libre Flash Glucose Monitoring System]
2012–2014: Principal Investigator for the CODIFI study: Comparing sampling methods in diabetic foot infections
2012–2013: Co-investigator for the ELIXA study: A randomised double-blind placebo controlled parallel group multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide as an add on to standard of care treatment in type 2 diabetic patients after an Acute Coronary Syndrome
2012–2013: Co-investigator for Treat 4 Ramadan Study: A study looking at Liraglutide vs. other oral hypoglycaemic agents in patients with Type 2 diabetes observing the month of Ramadan
2010–2014: Co-investigator for GHF study: A study comparing the various methods used in diagnosing and assessing diabetes control in diabetes and other health conditions
The usefulness of CRP as a marker of infection and the judicious use of antibiotics in DKA (09/05–07/06)
Helped identifying cases for various clinical trials and research projects at Oxford
Audits:
John Radcliffe Hospital, Oxford University Hospitals (2009); Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham (2011–):
The National Diabetes Inpatient Audit (NaDIA)
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham:
Audit Lead for Diabetes, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham (2016–)
2017: Adherence with the Renal Licences of Antidiabetic Medications in Diabetes Outpatient Clinics
2017: Glycaemic Control of People Referred to the Multidisciplinary Diabetic Foot Clinic
2016: The Management of Hypertension in Afro-Caribbean Patients with Type 2 Diabetes at a Large Teaching Primary Care Centre in Birmingham
2015: Understanding of Sick Day Rules in People Living with Diabetes
